Home / Inspections / 1151264

FDA Inspection 1151264 — South Florida Institute for Reproductive Medicine

South Florida Institute for Reproductive Medicine — FEI 3007787718

The FDA completed an inspection of South Florida Institute for Reproductive Medicine on September 1, 2021 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 1, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Naples, FL (United States)

Facility

Other inspections at this facility

  • 1312270 (NAI Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1204459 (NAI Wed Apr 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1029066 (NAI Mon Aug 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 717775 (NAI Thu Mar 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources